Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Capital Leases (2016 - 2023)

AtriCure (ATRC) has disclosed Capital Leases for 10 consecutive years, with $8.3 million as the latest value for Q3 2023.

  • On a quarterly basis, Capital Leases fell 11.34% to $8.3 million in Q3 2023 year-over-year; TTM through Sep 2023 was $8.3 million, a 11.34% decrease, with the full-year FY2022 number at $9.1 million, down 9.27% from a year prior.
  • Capital Leases was $8.3 million for Q3 2023 at AtriCure, down from $8.9 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $11.8 million in Q2 2019 to a low of $8.3 million in Q3 2023.
  • A 5-year average of $10.4 million and a median of $10.4 million in 2021 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: fell 3.27% in 2019, then dropped 11.34% in 2023.
  • AtriCure's Capital Leases stood at $11.8 million in 2019, then fell by 6.84% to $11.0 million in 2020, then fell by 8.09% to $10.1 million in 2021, then fell by 9.27% to $9.1 million in 2022, then decreased by 8.82% to $8.3 million in 2023.
  • Per Business Quant, the three most recent readings for ATRC's Capital Leases are $8.3 million (Q3 2023), $8.9 million (Q1 2023), and $9.1 million (Q4 2022).